Screener
Cogent Biosciences, Inc. COGT Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $181.17M+42.0% | $241.21M+91.4% | $312.01M+218% | $125.3M+29.1% | $127.6M+44.6% | ||
| $611.13M+454% | $625.17M+422% | $588.75M+212% | $265.59M+11.4% | $110.25M-59.9% | ||
| $804.82M+228% | $877.8M+247% | $910.36M+207% | $397.24M+16.3% | $245.01M-33.8% | ||
| $4.78M-18.4% | $5.3M-17.9% | $5.46M-15.6% | $5.27M-24.8% | $5.85M-20.5% | ||
| $834.55M+204% | $903.01M+218% | $937.61M+186% | $425.93M+10.9% | $274.82M-36.1% | ||
| $7.49M-55.0% | $13.74M-2.9% | $9.5M-20.9% | $16.03M+6.4% | $16.63M+85.2% | ||
| $59.3M+1.5% | $57.98M+17.6% | $63.95M+14.8% | $62.25M+17.3% | $58.42M+46.0% | ||
| $302.16M+152% | $295.31M+356% | $301.24M+321% | $123.47M+78.0% | $119.78M+111% | ||
| $171K+50.0% | $171K+50.0% | $161K+46.4% | $141K+28.2% | $114K+4.6% | ||
| -$1.38B-37.5% | -$1.29B-38.0% | -$1.19B-38.3% | -$1.09B-37.2% | -$1B-39.4% | ||
| $532.39M+243% | $607.69M+177% | $636.37M+148% | $302.46M-3.9% | $155.04M-58.5% | ||
| $834.55M+204% | $903.01M+218% | $937.61M+186% | $425.93M+10.9% | $274.82M-36.1% |
FAQ
- What are Cogent Biosciences, Inc.'s total assets?
- Cogent Biosciences, Inc. (COGT) holds $834.5M in total assets, up 203.7% year over year.
- How much debt does Cogent Biosciences, Inc. have?
- Cogent Biosciences, Inc. carries $20.8M in total debt against $532.4M of shareholders' equity, a debt-to-equity ratio of 0.04.
- How much cash does Cogent Biosciences, Inc. have?
- Cogent Biosciences, Inc. holds $181.2M in cash and equivalents.
- Can Cogent Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 13.57 — current assets exceed current liabilities.
- Where does Cogent Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Cogent Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.